Non-Deal Road Shows
Road shows are designed to introduce our clients to our extensive network of investment professionals, including portfolio and fund managers, analysts, retail brokers, investment advisors, and newsletter writers. After every meeting we follow up with every investor in order to ensure the meetings were a success, the client’s message was clearly received, and determine what can be done to improve future meetings. Each road show, whether it is for one day or one week, will consist of at least the following:
Identify and develop a list of potential investors from our proprietary database of investors as well as through company specific targeted research.
Disseminate company information in combination with meeting invitations.
Apply secondary screening process to ensure that potential attendees are appropriately familiar with our clients, including among other things their share price, market capitalization, sector, and exchange listing.
Provide clients with detailed road show schedules for one-on-one meetings, including name, company, address, and cross streets and sign-in sheets for group meetings.
Coordinate the printing of corporate presentations and other marketing collateral.
Manage trip logistics, including liaising with event coordinators, arranging ground transportation, providing flight and hotel recommendations, and arranging audio-visual support.
Members of our team are available for travel, which if requested we would greet and introduce investors to management, liaise with event coordinators, and provide tech support with respect to required audio-visual services.
Member of our team are not necessary for travel as investors have already heard the "pitch" from us and have accepted a meeting with management in order to learn more.
Provide complete contact information for all meeting attendees, including company, contact, phone, and email.
Provide comprehensive feedback from meeting attendees regarding the presentation, management, the company, and the company's opportunities going forward.
Distribute press releases, analyst reports, and other company updates to meeting attendees on an ongoing basis.
Disclaimer: Never invest in any stock unless you can afford to lose your entire investment. San Diego Torrey Hills Capital, Inc. is often compensated by client companies with restricted shares of stock or stock options which may cause a conflict in interest.
The information and content contained within this website or disseminated by either San Diego Torrey Hills Capital, Inc., its associates, and/or Cliff Mastricola, its President (collectively, “THC”) in any fashion, including email and social media sites such as Facebook, Twitter and Linkedin, is for informational purposes only and is not an offer to sell securities or a solicitation of offers to purchase securities and should not be construed to be investment advice. THC is not a broker-dealer, registered investment adviser, financial analyst, investment broker, financial adviser, or any sort of professional that would be deemed as an individual someone would rely upon for investment advice, and THC shall not be held liable for any investment or trading losses one may incur by using the information contained within this website or disseminated by THC. You should not construe any of the material contained within this website or disseminated by THC as business, financial, investment, trading, legal, regulatory, tax, or accounting advice, and you should consult your business adviser, attorney, and tax and accounting advisers concerning any contemplated transactions.
Information on this website or disseminated by THC, including but not limited to any client company press releases, investor presentations, corporate overviews, newsletters, analysts' reports, etc. is obtained from THC's client companies, public filings, or publicly available sources deemed to be reliable; however, THC takes no responsibility for verifying the accuracy of such information and makes no representation that such information is accurate or complete and consequently it should not be relied upon as such. The information is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject THC to any registration requirement within such jurisdiction or country. THC reserves the right to add, modify or delete any information on this website at any time.
In general, given the developmental stage of THC's client companies, as well as the lack of liquidity in shares of client companies, investing in such shares is highly speculative and carries a high degree of risk. Investing in microcap stocks is very risky due to extreme volatility. An investor in such securities should be prepared and able to bear loss of his or her entire investment and should perform extensive independent due diligence prior to any purchase or sale of securities.
Please be advised that any and all content, material or information regarding THC client companies which are prepared by any 3rd party may contain material inaccuracies and therefore should not be relied upon in making an investment decision.
The information contained in this website or disseminated by THC may contain “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be “forward looking statements.” Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated including (i) all of the risks and uncertainties associated with developmental businesses; (ii) any particular Clients' possible lack of capital and their ability to obtain capital as needed; (iii) intense competition for products and services within the Clients' industry; (iv) the timely development and market acceptance of the Clients' products, services or technologies; and (v) the successful integration of any acquisitions and lines of business. All information contained in this website or disseminated by THC that may include forward-looking statements pertaining to future anticipated projected plans, performance and developments; and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. There are a number of important factors that could cause actual events or actual results of the client companies to differ materially from these indicated by such forward-looking statements, many of which can be found in the company clients' SEC filings at www.sec.gov. THC and its company clients undertake no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of information disseminated by THC.
THC has been retained by its client companies as a consultant in the investor relations field and for related services, and as such, client companies have compensated THC by issuing restricted shares of the client company's common stock, making cash payments, and/or issuing stock options or stock warrants to purchase client company's common stock. THC will profit from its investor relations activities for its client companies. From time to time, THC and its officers and employees will own or acquire additional securities issued by its client companies and/or will dispose of securities issued by its client companies that they hold. THC does not undertake any obligation to provide any information on purchases and/or sales of securities issued by its client companies.
Specific amounts of compensation paid to THC for current client engagements are explicitly detailed as follows in order to be in full compliance with the Securities Act of 1933, Section 17(b). Compensation received pursuant to any previous and expired consulting agreements with any current clients, if any, are not included - however specifics of such compensation, if any, were fully disclosed during the term of any past agreements:
CohBar, Inc three thousand dollars per month and warrants to purchase one hundred and twenty five thousand shares of common stock. Excellon Resources six thousand dollars per month. Group Eleven nine thousand dollars per quarter and options to purchase two hundred thousand shares of common stock. Inovio, Inc. four thousand and five hundred dollars per month. MassRoots, Inc two million shares of restricted common stock. MGX Minerals, Inc five thousand dollars per month and options to purchase two hundred thousand shares of common stock Opsens six thousand dollars per month. Patriot One Technologies thirty two thousand nine hundred and sixty dollars and options to purchase two hundred thousand shares of common stock . Piedmont Lithium five thousand dollars per month and options to purchase one hundred and fifty thousand shares of common stock. Power Metals five thousand dollars per month and options to purchase two hundred and fifty thousand shares of common stock. Viscount Mining Corp. four thousand dollars per month and options to purchase two hundred thousand shares of common stock. Wize Pharma six thousand dollars per month and one hundred thirty-five thousand shares of restricted stock. Taseko Mines five thousand dollars per month and options to purchase seventy-five thousand shares of common stock. Newrange Gold four thousand dollars per month and options to purchase two hundred thousand shares of common stock. Antibe Therapeutics four thousand dollars per month and options to purchase two hundred thousand shares of common stock. Know Labs seventy-five thousand shares of restricted common stock. Nova Leap Health five thousand five hundred dollars per month. Jacksam Corp. two thousand dollars per month and two hundred fifty thousand shares of restricted common stock. CURE Pharmaceutical forty-five hundred dollars per month and twenty five thousand shares of restricted common stock. NervGen Pharma Corp. five thousand dollars per month and options to purchase one hundred thousand shares of common stock. Nymox Pharmaceutical six thousand dollars per month. CLS Holdings seventy-five hundred dollars per month. Oroco Mining five thousand dollars per month and options to purchase one hundred thousand shares of common stock. From time to time, THC and/or Cliff Mastricola may own or acquire additional securities issued by client companies and/or may dispose of securities issued by client companies. This may create a conflict of interest. THC and Cliff Mastricola do not undertake any obligation to provide any information on purchases and/or sales of securities issued by client companies.